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 
Abstract— Extra skeletal Myxoid Chondrosarcoma (EMC) is 
a rare soft tissue sarcoma, which primarily occurs deep in 
extremities, especially in the skeletal muscle or tendon. Unusual 
locations include tongue, retroperitoneum, spine, intracranium, 
testis, inguinal region, synovium, mammary gland, labium and 
pleura, however no case of has been described the aggressive 
involvement of lung with multiple canon ball metastatic atypical 
chondromyxoid neoplasm with unknown primary. 
We hereby present a 38 year old Asian male patient initially 
presented for cough and occasional blood stained sputum with 
chest pain since few days, found to have multiple canon ball 
lung lesions which histopathological suggestive of atypical 
chondromyxoid  sarcoma and primary source remained to be 
unknown. 
Index Terms— chondrosarcoma, extra skeletal, myxoid.  
 
I. INTRODUCTION 
  Extra skeletal myxoid chondrosarcoma (EMC) is a rare soft 
tissue sarcoma that was recognized as a distinct pathologic 
entity by Stout and Verner in 1953 [1], which primarily 
occurs deep in extremities, especially in the skeletal muscle 
or tendon. Unusual locations include tongue, retro 
peritoneum, spine, intracranium, testis, inguinal region, 
synovium, mammary gland, labium and pleura. However, it 
was not until 1972 that Enzinger and Shiraki [2] defined the 
clinic pathologic features of EMC, showing a relatively 
protracted clinical course and a better prognosis than that 
with conventional bone chondrosarcomas.  
In 1992, Saleh et al. [3] reassessed the clinical features of 
EMC in a series of 10 patients and showed the "indolent but 
resilient" nature of this neoplasm; 7 of the patients died of 
tumor up to 17 years after the initial diagnosis. 
Primary pulmonary malignancies are most commonly of 
epithelial origin. Tumours of other histologic differentiation 
have been described in association with the airway and 
bronchi; however primary tumours with cartilaginous or 
osteoid features originating in the lung are extremely rare and 
typically indicate metastatic disease. While cases of extra 
skeletal myxoid chondrosarcoma of the extremities are 
extremely infrequent, descriptions of this tumour histology 
arising from the lung is one of the rare and isolated to case 
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reports in the literature [4]. 
Primary lung cancers resembling EMC have been rarely 
reported as “primary pulmonary myxoid sarcoma (PPMS)”. 
Primary lung tumours resembling EMC include PPMS [4,5], 
pulmonary angiomatoid fibrous histiocytoma (AFH) [6], and 
pulmonary microcysticfibromyxoma [7]. PPMS is a rare 
tumour of uncertain differentiation, characterized by 
EMC-like histology and EWSR1-CREB1 fusion [4,5], and 
this entity would encompass “low-grade pulmonary myxoid 
sarcoma” [8] and “primary pulmonary EMC” [9]. Lung 
myoepithelioma with extensive myxoid changes may be 
another differential diagnosis of this case. However, most 
cases of myoepithelioma were S-100 protein+ and/or SMA+ 
[4,9]. 
Here by we present  case of young adult clinically 
manifested with  short duration of cough with blood tinged 
sputum ,CT imaging shows  multiple canon ball lesions of  
the lungs  and histopathogically by CT guided biopsy of lung 
tissue consistent with features of Atypical Chondro myxoid 
neoplasm and there was no primary found to be associated.  
 
II.  CASE PRESENTATION 
A 38 year old Indian male with no previous co morbidities 
presented with history of cough dry in nature since few 
weeks, occasionally with blood stained sputum increased 
during last 3 days, associated with right sided pleuritic chest 
pain. He gave the history of weight loss 5-6 kgs in span of 4 
months. Clinical examination was unremarkable. During 
initial work up CXR showed multiple well defined nodules 
and masses in both lungs, largest noted in right upper lobe,  
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suggestive of metastasis; Superior mediastinum widening 
due to lymphadenopathy ; left sided minimal pleural effusion 
noted figure citation1. Further followed with CT Chest which 
was suggestive of  a). Both lung shows diffuse metastasis of 
varying size giving a Cannon Ball appearance, largest noticed 
in right upper lobe measuring 3.5 x 3.2 cms; b). Multiple 
pleural metastatic lesions also noticed with left side pleural 
effusion; c). Multiple mediastinal and hilar lymph node 
masses+; d). Oesophagus displaced laterally by nodal mass 
figure citation 2. 
CT Guided Biopsy of Lung tissue showed features of 
atypical chondromyxoid sarcoma, morphological features 
resembles those seen in extra skeletal myxoid 
chondrosarcoma. Patients vitals where stable and spo2 of 96 
on room air, other systemic examination was in normal limits 
.To Rule out  the primary cause pan CT was done and there 
Young Adult with Canon Ball Lung Metastasis and 
Unknown Primary: A Case of Primary Pulmonary 
Myxoid Sarcoma 
Dr. Hassan Abu Zaid, Dr. Khalid Farooqui, Dr. Riyadh Ali Hammamy, Dr. Mohamed Shariff 
Young Adult with Canon Ball Lung Metastasis and Unknown Primary: A Case of Primary  
Pulmonary Myxoid Sarcoma 
                                                                                85                                                                 www.wjrr.org 
 
was no foci present except right upper lobe lung mass. Upper 
and lower endoscopy was normal. 
Images: 
 
Low power magnification (10 ×): multilobulated mass with 
fibrous septa and myxoid background (figure  A). High power 
magnification (20 ×): atypical epithelioid cells with round to 
oval nuclei, moderate nuclear atypia arranged in cords, 
 
(Figure C) 
   





Extra skeletal Myxoid Chondrosarcoma (EMC) is a rare soft 
tissue sarcoma, which primarily occurs deep in extremities, 
especially  in the skeletal muscle or tendon, recognized as a 
distinct pathologic entity by Stout and Verner in 19531. In 
1992, Saleh et al. [3] reassessed the clinical features of EMC 
in a series of 10 patients and showed the "indolent but 
resilient" nature of this neoplasm. 
Primary pulmonary malignancies are most commonly of 
epithelial origin. Tumours of other histologic differentiation 
have been described in association with the airway and 
bronchi; however primary tumours with cartilaginous or 
osteoid features originating in the lung are extremely rare and 
typically indicate metastatic disease. While cases of extra 
skeletal myxoid chondrosarcoma of the extremities are 
extremely infrequent, descriptions of this tumour histology 
arising from the lung is one of the rare and isolated to case 
reports in the literature. The histogenesis of EMC is still a 
subject of controversy. However, chondroblastic 
differentiation had been supported by ultrastructural [10-15] 
and histochemical [16-18] studies. And also cytogenetic and 
molecular analyses have shown that EMC is a distinct entity 
with the characteristic translocation t(9;22) involving the 
EWS gene (22q12) and the TECgene (9q22) in a majority of 
the cases. The classic histologic appearance with multiple 
myxoid lobules, separated by fibrous septa, and tumour cells 
arranged in cord or strands in a netlike or linear 
interconnected pattern like a “string of pearl” [19].  Immuno - 
histochemical, most EMC are positive for vimentin and 
focally positive forS100, negative for cytokeratin (except 
EMA) and GFAP. 
Primary chondrosarcomas of the lung are extremely rare with 
only isolated case reports found in the literature. The largest 
series reported by Kalhor et al. highlights four cases-two of 
myxoid character and two hyaline type [20]. In 2012, two 
case reports were published describing one EMC [21] in a 
51-year old female with severe anaemia and primary 
pulmonary myxoid sarcoma with EWSR1 CREB1 fusion, 
resembling EMC [3]. In November 2015 there was another 
rare case reported of 69 year old male with left lung upper 
lobe mass, which was finally diagnosed histopathological as 
Extra Skeletal Pulmonary Myxoid Chondrosarcoma [22]. 
With the present case given its rarity, atypical aggressive 
feature of this tumour involving both the lung where the 
primary source was not identified and manifesting in very 
short duration of time. It’s difficult to state regarding the 
treatment and further prognosis of the described patient.  The 
aggressive activity of chondrosarcoma depends on the tumour 
histology and is widely variable. EMC are generally low 
grade chondrosarcoma, but recent studies have demonstrated 
high potential for metastasis and local recurrence suggesting 
a more intermediate malignancy of this tumour [23]. 
 
Chondrosarcomas are notoriously resistant to conventional 
chemotherapy and radiation therapy, and resection remains 
the main stay of treatment. But in our case there are multiple 
lesions involving both lungs which rules out the resection 
mode of treatment. In advanced or metastatic tumours, recent 
studies with novel chemotherapy regimens have not 
demonstrated increased survival [24].  Further efforts are 
needed in this area to define a more effective strategy. The 
overall prognosis of ECM is difficult to estimate given the 
rarity of the tumour. Considering the rarity of this case with 
multiple lesions and the poor response of chondrosarcomas to 
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